Investing

Atossa Therapeutics : ATOS

ATOS

Stock Data

$5.33

$0.04 (0.74%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops drugs in the areas of oncology and infectious diseases. The company is headquartered in Seattle, Washington.

All Atossa Therapeutics Articles

1 Article

Chris Lange | Jul 6, 2021 at 10:05 AM EDT

Tuesday’s Early Meme Stock Action Sees Clover Health Tumbling, AMC Higher and More

The WallStreetBets community has been a resounding force in the market since January causing many investors to reevaluate their positions.…